top of page

Ribocure Clinic: Accelerating Clinical Trials and Improving Quality

At COG Nordics in April 2024, Sara Svedlund, Head of Ribocure Clinic and Medical Director, presented the innovative approach and ambitious plans of Ribocure Clinic, a clinical trial unit located in the heart of GoCo Health City in Göteborg, Sweden. As a subsidiary of Suzhou Ribo Life Science Co. Ltd., a leading Chinese company devoted to siRNA drug development, Ribocure Clinic is poised to make significant strides in the field of clinical research.

Sara Svedlund, Head of Ribocure Clinic and Medical Director
Sara Svedlund, Head of Ribocure Clinic and Medical Director

Key takeaways from Sara's presentation include:

  1. Quality, speed, and cost-effectiveness are the cornerstones of Ribocure Clinic's mission. By focusing on these aspects, the clinic aims to deliver excellence in clinical trials.

  2. Ribocure Clinic boasts a state-of-the-art facility equipped with advanced imaging devices, dedicated medical research staff, and a robust quality assurance system. This infrastructure enables the clinic to conduct high-quality clinical trials with minimal variability.

  3. The clinic's strategies for accelerating trial start-up include pre-screening trials, an in-house patient registry, and extensive networks for fast participant recruitment. These measures are expected to significantly reduce the time and cost associated with clinical trials.

  4. Ribocure Clinic's upcoming pre-screening study, the Deep-phenotypinG Of Residual CardiOvascular Risk (GO-CO) study, aims to stratify individuals based on clinical imaging and dynamic tests, understand disease mechanisms, and identify biomarkers predicting cardiovascular disease risk. This study will facilitate recruitment for future Phase 2a trials.

  5. The clinic's vision for the future includes innovative approaches such as mobile care, home visits, and targeted recruitment strategies to further enhance the efficiency and accessibility of clinical trials.

With its cutting-edge facilities, experienced staff, and forward-thinking strategies, Ribocure Clinic is well-positioned to make a significant impact on the landscape of clinical research. As the clinic continues to grow and expand its capabilities, it is likely to play an increasingly important role in advancing the development of novel therapies and improving patient outcomes.

Sara Svedlund, Head of Ribocure Clinic and Medical Director
Sara Svedlund, Head of Ribocure Clinic and Medical Director

Missed this one? Join our next European meeting in Amsterdam this November, full details here: 


bottom of page